Behavioral Health Program for Short-Stay Nursing Facility Residents & Care Partners
The goal of this clinical trial is to test a behavioral health program (Interventions for Stressful Transitions in Later Life, InSTILL) for skilled nursing facility residents and their primary support person. The main questions it aims to answer is whether the program is program is feasible, satisfactory, and helpful. The researchers will compare the InSTILL program to minimally enhanced usual care. Participants will be randomly assigned to receive either the InSTILL program or minimally enhanced usual care…
Conditions studied
Nursing Home Resident, Skilled Nursing Facility, Depression, Feasibility Studies, Caregiver
About this study
The goal of this clinical trial is to test a behavioral health program (Interventions for Stressful Transitions in Later Life, InSTILL) for skilled nursing facility residents and their primary support person. The main questions it aims to answer is whether the program is program is feasible, satisfactory, and helpful. The researchers will compare the InSTILL program to minimally enhanced usual care. Participants will be randomly assigned to receive either the InSTILL program or minimally enhanced usual care. Participants will complete assessments at three timepoints (all) and a brief-exit interview.
Interventions
- Behavioral: Interventions for Stressful Transitions in Later Life — The Interventions for Stressful Transitions in Later Life (InSTILL) intervention is for skilled nursing facility residents and their care partners experiencing elevated levels of psychological distress. The intervention is designed to improve life management skills, emotion regulation skills, and dyadic coping skills with the goal of reducing depression symptoms among both dyad members (i.e., resident and care partner).
Primary outcomes
- Treatment Credibility (peri-intervention)
- Client Satisfaction Questionnaire (immediately after the intervention)
- Feasibility of Recruitment (baseline, pre-intervention)
- Feasibility of Data Collection (1 month follow-up)
- Treatment Adherence (immediately after the intervention)
- Clinician Fidelity (immediately after the intervention)
- Adverse Events (1 month follow-up)
- Treatment Acceptability Survey (immediately after the intervention)
Eligibility information
Study locations
- Massachusetts General Hospital, Boston, Massachusetts 02114 United States
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.